2004 – Pharmacotherapy during Pregnancy: Methadone, Buprenorphine, and Neonatal Abstinence Syndrome

2004 Conference Workshop
PowerPoint Presentation

  • Karol Kaltenbach, PhD, Jefferson Medical College, Philadelphia, PA
  • John McCarthy, MD, Bi-Valley Medical Clinic, Sacramento, CA
  • Hendree Jones, PhD, Johns Hopkins University, Baltimore, M.D.

This workshop will address maternal and infant outcomes utilizing methadone and buprenorphine pharmacotherapy. Presenters will discuss the relationship of maternal methadone dose and neonatal abstinence, maternal and infant outcomes for women treated with up to 190mg of methadone per day, and the safety and efficacy of using buprenorphine during pregnancy.

Share This